Fund · State Street(R) SPDR(R) MSCI EAFE StrategicFactors(SM) ETF · measured from SEC filings
QEFA holdings
QEFA reports 646 holdings and behaves like 181.8 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-06-30. The fact sheet publishes the first number; this page computes the second, and traces it across 28 quarters of filings.
Measured concentration
as of 2026-06-30Read this figure with the following in mind
2.5% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 165.5
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 27 issuer countries, 0.83% restricted securities.
What stands out
as of 2026-06-30QEFA's largest investment is ASML Holding NV at 2.52% of net assets. Novartis AG and AstraZeneca PLC follow; the three together are 6.51%. Ten companies are 15.54% of the fund; the other 636 share the rest. Among the 721 equity funds measured here, QEFA behaves like 181.8 holdings against a median of 42.4 — 4.3 times the median. Across 28 quarterly filings QEFA has held roughly steady since 2019-09-30 (208 then, 181.8 now). Between the 2026-03-31 and 2026-06-30 filings 15 positions were added and 28 dropped; 9.6% of the weight moved. Japan is the largest country at 21.42% of the portfolio, across 27 countries in the filing.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2019
28Between 2019-09-30 and 2026-06-30, QEFA went from behaving like 208 equally weighted positions to 181.8 — 13% fewer, while its top ten went from 14.2% to 15.54% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-06-30 | 646 | 181.8 | 15.54% | 2.54% |
| 2026-03-31 | 658 | 181 | 16.04% | 2.33% |
| 2025-12-31 | 661 | 190.1 | 15.47% | 2.19% |
| 2025-09-30 | 662 | 198.8 | 14.72% | 2.23% |
| 2025-06-30 | 661 | 200 | 14.91% | 1.97% |
| 2025-03-31 | 653 | 187.6 | 15.46% | 2.18% |
| 2024-12-31 | 655 | 192 | 15.38% | 1.93% |
| 2024-09-30 | 664 | 188.8 | 15.82% | 2.04% |
Earlier filings (20 more, back to 2019-09-30)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-06-30 | 676 | 176.7 | 16.96% | 2.34% |
| 2024-03-31 | 677 | 179.7 | 17% | 2.33% |
| 2023-12-31 | 685 | 184.3 | 16.95% | 2.45% |
| 2023-09-30 | 694 | 183.9 | 16.49% | 2.59% |
| 2023-06-30 | 700 | 183.9 | 16.72% | 2.44% |
| 2023-03-31 | 701 | 173 | 17.67% | 2.87% |
| 2022-12-31 | 705 | 175.5 | 17.45% | 2.61% |
| 2022-09-30 | 704 | 171.4 | 17.66% | 2.82% |
| 2022-06-30 | 702 | 174.4 | 17.78% | 2.71% |
| 2022-03-31 | 697 | 183.9 | 16.07% | 2.65% |
| 2021-12-31 | 693 | 188.9 | 15.97% | 2.67% |
| 2021-09-30 | 698 | 186.6 | 16.38% | 2.53% |
| 2021-06-30 | 697 | 186.8 | 16.33% | 2.59% |
| 2021-03-31 | 705 | 214.5 | 14.82% | 2.2% |
| 2020-12-31 | 709 | 209.7 | 14.89% | 2.38% |
| 2020-09-30 | 697 | 217.8 | 14.43% | 2.46% |
| 2020-06-30 | 699 | 217.4 | 14.26% | 2.38% |
| 2020-03-31 | 653 | 173.2 | 17.16% | 3.17% |
| 2019-12-31 | 655 | 209.6 | 14.84% | 2.53% |
| 2019-09-30 | 642 | 208 | 14.2% | 2.63% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
2.49% collateralQEFA's filing lists 647 positions including 2.49% of net assets in securities-lending cash collateral. Counted as filed the fund reads 165.5 effective holdings with a top ten of 16.88%; on its own investments — the figure above — it reads 181.8 with a top ten of 15.54%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-06-30The 15 largest of 646 positions in QEFA's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: QEFA.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | ASML Holding NV | 2.54% | 2.5% |
| 2 | Novartis AG | 2.14% | 4.7% |
| 3 | AstraZeneca PLC | 1.88% | 6.6% |
| 4 | Roche Holding AG | 1.86% | 8.4% |
| 5 | Nestle SA | 1.72% | 10.1% |
| 6 | Unilever PLC | 1.15% | 11.3% |
| 7 | Shell PLC | 1.09% | 12.4% |
| 8 | Zurich Insurance Group AG | 1.06% | 13.4% |
| 9 | Allianz SE | 1.06% | 14.5% |
| 10 | BHP Group Ltd | 1.05% | 15.5% |
| 11 | Tokyo Electron Ltd | 1.02% | 16.6% |
| 12 | Novo Nordisk A/S | 1.01% | 17.6% |
| 13 | GSK PLC | 0.90% | 18.5% |
| 14 | ABB Ltd | 0.89% | 19.4% |
| 15 | SAP SE | 0.86% | 20.2% |
By country of issuer
as of 2026-06-30Share of QEFA's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| Japan | 21.96% |
| United Kingdom | 14.49% |
| Switzerland | 12.55% |
| France | 8.05% |
| Germany | 7.04% |
| Netherlands° | 6.26% |
| Australia | 5.74% |
| Spain | 3.53% |
Returns the fund reported
2019-07 – 2026-06Monthly total returns from Item B.5 of QEFA's own filings, 84 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference 0.38 percentage points over 84 months, which is roughly the distributions. Every month with the filing it came from: QEFA.json · all funds.
Who borrows QEFA's shares
2026-06-30The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-06-30, $47m was out to 19 borrowers, 4.56% of net assets. The largest, GOLDMAN SACHS INTERNATIONAL, held 28.3% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| GOLDMAN SACHS INTERNATIONAL | $13m | 28.3% |
| J.P. MORGAN SECURITIES PLC | $10m | 21.2% |
| CITIGROUP GLOBAL MARKETS INC. | $6m | 13.6% |
| TD SECURITIES (USA), LLC | $3m | 7.4% |
| BofA Securities, Inc. | $3m | 5.5% |
Cash collateral reported against the loan: 2.49% of net assets, 54.6% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter QEFA has filed, with each borrower: QEFA.json · all funds.
Since the previous filing
2026-03-31 → 2026-06-30656 positions became 643: 15 added (0.3% of the fund at the later date), 28 dropped (1.1% at the earlier date). Half the sum of all weight changes, a turnover proxy: 9.6%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of QEFA compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-03-31 | 2026-06-30 | Largest decreases | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|
| Rolls-Royce Holdings PLC | 0.03% | 0.67% | Shell PLC | 1.58% | 1.09% |
| Airbus SE | 0.08% | 0.61% | TotalEnergies SE | 1.29% | 0.80% |
| Tokyo Electron Ltd | 0.59% | 1.02% | Eni SpA | 0.84% | 0.53% |
| Sony Group Corp | 0.14% | 0.54% | Equinor ASA | 0.76% | 0.46% |
| ASML Holding NV | 2.23% | 2.54% | Glencore PLC | 0.40% | 0.18% |
| Novo Nordisk A/S | 0.72% | 1.01% | BP PLC | 0.68% | 0.49% |
New: Azrieli Group Ltd (0.06%), Mitsui Kinzoku Co Ltd (0.05%), Wise Group PLC (0.05%), Ayvens SA (0.03%), OPC Energy Ltd (0.03%), Tower Semiconductor Ltd (0.02%). Gone: TIS Inc (0.14%), Tokyu Corp (0.13%), ZOZO Inc (0.09%), Sekisui Chemical Co Ltd (0.09%), Oracle Corp Japan (0.09%), Shimadzu Corp (0.08%).
Asset categories and pricing
as of 2026-06-30| Asset category (as filed) | Share of investments |
|---|---|
| equity EC | 97.19% |
| short-term investment STIV | 2.46% |
| preferred equity EP | 0.35% |
100.0% of QEFA is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of QEFA (181.8). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| HFXI NYLIM FTSE International Equity Currency Neutral ETF | 828 | 174.1 | 16.21% | 2026-07-31 |
| JVAL JPMorgan U.S. Value Factor ETF | 396 | 177.1 | 17.1% | 2026-07-31 |
| ESGD iShares ESG Aware MSCI EAFE ETF | 376 | 179 | 13.98% | 2026-05-31 |
| AVIV Avantis International Large Cap Value ETF | 653 | 179.3 | 14.65% | 2026-05-31 |
| ACWX iShares MSCI ACWI ex U.S. ETF | 1,902 | 181.2 | 15.66% | 2026-07-31 |
| ROUS Hartford Multifactor US Equity ETF | 322 | 184.1 | 12.04% | 2026-07-31 |
| ACWV iShares MSCI Global Min Vol Factor ETF | 416 | 185.1 | 12.57% | 2026-05-31 |
| QINT American Century Quality Diversified International ETF | 362 | 185.9 | 12.13% | 2026-05-31 |
| GXUS Goldman Sachs MarketBeta Total International Equity ETF | 2,465 | 187.6 | 15.57% | 2026-05-29 |
| FNY First Trust Mid Cap Growth AlphaDEX Fund | 226 | 187.9 | 8.32% | 2026-07-31 |
Essays that examine QEFA
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.